Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein

Nature

Volumn 386, Issue 6621, 1997, Pages 177-181

  Peeper, Daniel S ^a,b   Upton, Todd M ^a   Ladha, Mohamed H ^a   Neuman, Elizabeth ^a   Zalvide, Juan ^a   Bernards, René ^b   DeCaprio, James A ^a   Ewen, Mark E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DNA; EPIDERMAL GROWTH FACTOR; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; PLATELET DERIVED GROWTH FACTOR; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STRAIN 3T3; CONTROLLED STUDY; DNA SYNTHESIS; EMBRYO; FIBROBLAST CULTURE; MITOGENESIS; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; RETINOBLASTOMA; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030941460     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/386177a0     Document Type: Article

References (30)

1. Pardee, A. B. G1 events and regulation of cell proliferation. Science 246, 603-608 (1989).
2. Pronk, G. J. & Bos, J. L. The role of p21ras in receptor tyrosine kinase signalling. Biochim. Biophys. Acta 1198, 131-147 (1994).
3. Marshall, C. J. Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185 (1995).
4. Dobrowolski, S., Harter, M. & Stacey, D. W. Cellular ras activity is required for passage through multiple points of the G0/G1 phase in Balb/c 3T3 cells. Mol. Cell. Biol. 14, 5441-5449 (1994).
5. Feramisco, J. R., Gross, M., Kamata, T., Rosenberg, M. & Sweet, R. W. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 38, 109-117 (1984).
6. Stacey, D. W. & Kung, H. F. Transformation of NIH 3T3 cells by microinjection of Ha-ras protein. Nature 310, 508-511 (1984).
7. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323-330(1995).
8. Mulcahy, L. S., Smith, M. R. & Stacey, D. W. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313, 241-243 (1985).
9. Lukas, J. et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375, 503-506 (1995).
10. Koh, J., Enders, G. H., Dynlacht, B. D. & Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375, 506-510 (1995).
11. Feig, L. A. & Cooper, G. M. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8, 3235-3243 (1988).
12. Cai, H., Szeberenyi, J. & Cooper, G. M. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction. Mol. Cell. Biol. 10, 5314-5323 (1990).
13. Medema, R. H., Herrera, R. E., Lam, F. & Weinberg, R. A. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl Acad. Sci. USA 92, 6289-6293 (1995).
14. Guan, K.-L. et al. Growth suppression by p18, a p16INK4/MTS1-and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8, 2939-2952 (1994).
15. Sherr, C. J. & Roberts, J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163 (1995).
16. Herrera, R. E. et al. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16, 2402-2407 (1996).
17. Lukas, J., Bartkova, J., Rohde, M., Strauss, M. & Bartek, J. Cyclin D1 is dispensable or G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15, 2600-2611 (1995).
18. Sherr, C. J. Mammalian G1 cyclins. Cell 73, 1059-1065 (1993).
19. Lavoie, J. N., L'Allemain, G., Brunet, A., Muller, R. & Pouysségur, J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271, 20608-20616 (1966).
20. Albanese, C. et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270, 23589-23597 (1995).
21. Filmus, J. et al. Induction of cyclin D1 overexpression by activated ras. Oncogene 9, 3627-3633 (1994).
22. Liu, J.-J. et al. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15, 3654-3663 (1995).
23. Winston, J. T., Coats, S. R., Wang, Y.-Z. & Pledger, W. J. Regulation of the cell cycle machinery by oncogenic Ras. Oncogene 12, 127-134 (1996).
24. Serrano, M., Gomez-Lohoz, E., DePinho, R. A., Beach, D. & Bar-Sagi, D. Inhibition of Ras-induced proliferation and transformation by p16INK4. Science 267, 249-252 (1995).
25. Hatakeyama, M., Brill, J. A., Fink, G. R. & Weinberg, R. A. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev. 8, 1759-1771 (1994).
26. Zalvide, J. & DeCaprio, J. A. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15, 5800-5810 (1995).
27. -/- muscle cells. Science 264, 1467-1471 (1994).
28. Ewen, M. E. et al. Functional interactions of the retinoblastoma protein wrih mammalian D-type cyclins. Cell 73, 487-497 (1993).
29. Serrano, M., Hannon, G. J. & Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/cdk4. Nature 366, 704-707 (1993).
30. Ewen, M. E., Oliver, C. J., Sluss, H. K., Miller, S. J. & Peeper, D. S. p53-dependent repression of CDK4 translation in TGF-β-induced cell-cycle arrest. Genes Dev. 9, 204-217 (1995).